@FiercePharma: NICE to be sidelined, minister confirms. Report | Follow @FiercePharma
> AstraZeneca has sued Watson Pharmaceuticals to block the launch of a generic version of Crestor, a cholesterol-lowering medicine and the company's top seller. Report
> Eli Lilly and Merck KGaA's Erbitux helped a group of cancer patients thought to be immune to the treatment in a study that contradicts earlier assumptions of the way the drug works in those with a genetic mutation. News
> The Australian Competition and Consumer Commission postponed its decision on whether to allow a bid by Aspen Pharmacare for Sigma Pharmaceuticals' generic drugs division. Item
> PhRMA says a new Puerto Rico law to tax offshore manufacturers will "dramatically hinder" biopharma companies. Article
> Attorneys general in Illinois, Oregon and California said on Tuesday that Bayer agreed to a $3.3 million settlement over misleading claims that the drugmaker's vitamins reduced men's risk of prostate cancer. News
> Abbott Laboratories sued generics maker Anchen Pharmaceuticals in federal court in Delaware for infringing a U.S. patent for the kidney drug Zemplar. Story
Biotech News
@FierceBiotech: Analysts take on obesity drugs turns grim after lorcaserin CRL. Report | Follow @FierceBiotech
@JohnCFierce: Rodman & Renshaw analyst Elemer Piros on the future of obesity drugs: "This whole space is pretty much dead." News | Follow @JohnCFierce
> Corengi tech could enlarge pool of trial subjects. Report
> Bonfiglio named president, CEO of Transdel. News
> Myriad gains from Abbott testing deal. Story
> Index founds Mind-NRG with $13.8M investment. Article
> PacBio raises $200M with IPO. News
Drug Delivery News
> Highland looks for partners for abuse-resistant prescriptions. Story
> NCI rewards DNA/RNA nanomotor work with $2.5M. Item
> 'Stapled peptides' still the talk of the town. Report
> Chinese microneedle company wins Silver from WSJ. Story. Article
> Georgia Tech, Emory use NCI grants, nanoparticles to target cancers. News
> DIY drug administration on rise. Story
Medical Devices News
> Edwards, Hospira, KCI discuss Q3 results. Story
> ExonHit backs out of $22.5M RedPath buyout. Item
> How safe are endoscopies? Report
> Boston Sci looks at more acquisitions as Asthmatx deal closes. Article
> Can brain signals can control prosthetic arms? Story
> SpectraScience announces strategic restructuring. News
And Finally... It could be selling season for pharmacy benefit managers, with Walgreen and Cigna rumored to be selling their PBM units. Report